Here are some cancer types that are treated with immunotherapy.

• Lung Cancer: Immunotherapy has shown efficacy in treating both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
• Melanoma: Immunotherapy, particularly immune checkpoint inhibitors, has been successful in treating melanoma, a type of skin cancer.
• Breast Cancer: Certain subtypes of breast cancer, such as triple-negative breast cancer, may respond positively to immunotherapy.
• Bladder Cancer: Immunotherapy, including immune checkpoint inhibitors, is used to treat some forms of bladder cancer.
• Kidney Cancer: Immunotherapy is utilized as a treatment option for renal cell carcinoma, the most common type of kidney cancer.
• Head and Neck Cancer: Some patients with head and neck cancers, including squamous cell carcinoma, may benefit from immunotherapy.
• Colorectal Cancer: Immunotherapy is being investigated as a treatment for colorectal cancer, particularly in advanced or metastatic cases.
• Hodgkin Lymphoma: Immunotherapy, such as checkpoint inhibitors, is used in the treatment of Hodgkin lymphoma.
• Non-Hodgkin Lymphoma: Certain types of non-Hodgkin lymphomas may respond to immunotherapy, including CAR-T cell therapy.
• Liver Cancer: Immunotherapy is being explored as a treatment option for hepatocellular carcinoma, the most common type of liver cancer.

Immunotherapy’s broad applicability across various cancer types underscores its potential as a promising and versatile approach to improving outcomes in cancer treatment.